INTRODUCTION {#sec1-1}
============

The inflammatory bowel diseases (IBD) refer essentially to two different but closely related conditions, Crohn\'s disease and ulcerative colitis. Although the etiology of IBD remains unclear, there are evidences that it involves immune, genetic and environmental factors, which are, in turn, related to the initiation and progression of colitis ([@ref1]). Intestinal mucosal inflammation as a characteristic feature of IBD is induced by increasing in the activity of some mucosal immune cells where the T-helper cells play an important role ([@ref2]). Indeed, it is a loss of homeostasis of immune cells that results in intestinal inflammation ([@ref3]). Main current therapies of IBD are aminosalicylate derivatives and corticosteroids being used through various routes ([@ref4]), but several side effects and/or lack of full effectiveness are common problematic features of current regular treatments. Therefore, alternative and traditional therapies are largely considered in the IBD patients for several years ([@ref5][@ref6]). *Carum carvi* L. (*C. carvi*, Caraway) as an important medicinal plant from Apiaceae family has been cultivated for long time in the north and center of Europe, Egypt, Australia, China and Iran ([@ref7]). It is traditionally used as a spice in foods and beverages and as an alternative herbal medicine for GI ailments including dyspepsia, and various spasmodic conditions, bloating, diarrhea and in flatulent colic ([@ref8]). It is diuretic and expectorant and used for increasing maternal milk and dysmenorrhea ([@ref9][@ref10]). Caraway has both anti-hyperglycemic and anti-hyperlipidemic activities in STZ-induced diabetic rats ([@ref11]). Its volatile oil probably has a protective role in kidney tissue against oxidative injury in advanced stages of sepsis ([@ref12]) and it is hepatoprotective against carbon tetrachloride-induced liver toxicity in rats ([@ref13]).

Caraway has also been used in bronchopulmonary disorders as cough remedy and demulcent ([@ref14]). Vapors from caraway seeds have been reported to be effective in relieving pain and inflammation in patients suffering from lumbar pains and rheumatism ([@ref15]). Additionally there are numerous studies about the treatment of gastrointestinal disorders like *Helicobacter pylori* - induced gastritis ([@ref16]) and relaxant effect of ethanol extract of caraway on isolated intestinal smooth muscle cells of the guinea pig ([@ref17]). This response may explain, in part, the beneficial effects of caraway in relieving gastrointestinal symptoms associated with dyspepsia ([@ref18]). Two important natural compounds of caraway, carvone and limonene are mucoprotective on duodenal peptic ulcer and gastroduodenitis and have antiulcerogenic effect ([@ref19]). Due to the antiulcerogenic ([@ref20]), antioxidative ([@ref21]), antispasmodic ([@ref22]) and immunomodulatory ([@ref23]) properties of caraway, it is suggested that it has a high therapeutic potential for IBD conditions.

In this study, we evaluated the anticolitic effects of extract and essential oil of *C. carvi* fruits at various doses and via two administration routes in animal rat model of experimental TNBS-induced colitis.

MATERIALS AND METHODS {#sec1-2}
=====================

Plant material {#sec2-1}
--------------

Fruits of *C. carvi* L. procured from Istanbul, Turkey were donated on October, 2008 by the Mashhad School of Pharmacy, Mashhad, Iran.

Preparation and analysis of extract {#sec2-2}
-----------------------------------

*C. carvi* fruits (300 g) were air-dried and finely powdered, soaked in enough volume of ethanol:water (70:30) for 1 h and extracted using percolation apparatus which was maintained for 48 h to accomplish a complete extraction. The extract was shaken, filtered and evaporated in a rotary evaporator under reduced pressure until a semisolid extract was obtained ([@ref7][@ref24]). According to the British Pharmacopoeia the concentrated extract was freeze-dried to obtain a dry powdered extract. Test doses were eventually prepared by reconstitution of this dried extract in water ([@ref25][@ref26]).

Preparation and analysis of essential oil {#sec2-3}
-----------------------------------------

Caraway essential oil was obtained by hydro-distillation method according to the method described by the Iranian Herbal Pharmacopoeia. The essential oil was then analyzed by thin layer chromatography (TLC). The analysis was carried out on silica gel 60 F~254~ precoated plates, layer thickness: 250 μm (Merck, Darmstadt, Germany) and developed in different systems where Toluene:EtOAc (93:7) gave the highest resolution. The spots were visualized by UV illumination and vanilline/H~2~SO~4~ reagent ([@ref7]).

Animals {#sec2-4}
-------

Male Wistar rats weighting 200 ± 20 g bred in animal house of Isfahan School of Pharmacy were housed in wire-bottomed cages of three animals in each cage at room temperature and ambient humidity, fed with normal rat chow and water *ad libitum*. Experiments were performed only after the rats had acclimated to the above environment. Each animal was only used once for the experiments. All experiments were carried out in accordance with international guideline outlined in the Guide for the Care and Use of Laboratory Animals ([@ref27]).

Chemicals {#sec2-5}
---------

Prednisolone and hydrocortisone acetate were purchased from Iran Hormone Pharmaceutical Co. (Tehran, Iran). Asacol® (mesalazine microgranules) was obtained from Iran Darou Co. (Tehran, Iran). Trinitrobenzene sulfonic acid (TNBS) was purchased from Sigma (St. Louis, MO). All of the organic solvents were of analytical grade and Merck brand (Darmschtdat, Germany).

Test samples including suspension of reference drugs and caraway extract or emulsion of essential oil were freshly prepared using 0.2% tween 80 in distilled water as vehicle for oral (p.o.) and intraperitoneal (i.p.) administration.

Grouping {#sec2-6}
--------

Seventeen groups of animals were randomly assigned to sham (normal), negative control, test, and reference (positive control) groups of at least 6 rats as following:

Sham groups, treated with vehicle p.o. (5 ml/kg) and i.p. (2 ml/kg) without induction of colitis.

Negative control groups, treated with vehicle p.o. (5 ml/kg) and i.p. (2 ml/kg), after induction of colitis.

Extract groups, treated orally with *C. carvi* hydroalcoholic extract (CHE) at doses of 100, 200, and 400 mg/kg, and intraperitoneally at doses of 100 and 400 mg/kg.

Essential oil groups, treated orally with *C. carvi* essential oil (CEO) at doses of 100, 200, and 400 μl/kg, and intraperitoneally at doses of 100 and 400 μl/kg.

Reference groups, treated with prednisolone (4 mg/kg, p.o.), Asacol® (mesalazine microgranules, 100 mg/kg, p.o.) and hydrocortisone acetate (20 mg/kg, i.p.), respectively.

All the treatments were started 6 h after colitis induction and continued daily for 5 days.

Induction of Colitis {#sec2-7}
--------------------

Rats were fasted for 36 h with free access to water prior to induction of colitis. When the health of animals was confirmed, the rats were lightly anesthetized with diethylether. A flexible plastic rubber catheter with an outside diameter of 2 mm was inserted rectally into the colon; and its tip was kept 8 cm proximal to the anus. TNBS (100 mg/kg) dissolved in 50% ethanol (v/v) was instilled into the colon lumen through the rubber catheter (0.5 ml) while normal saline was instilled as control ([@ref28]).

Evaluation of the colonic damage {#sec2-8}
--------------------------------

Rats were euthanized using over-dose ether anesthesia at the day of six. The abdomen was opened and the colon, 8 cm in length and 3 cm proximal to the anus, was excised and incised longitudinally and washed with normal saline. Wet colon was then weighed and weight/length ratio was determined for each specimen. Macroscopic mucosal damage was evaluated using the validated grading scale according to Morris and coworkers ([@ref29]). Scores were: 0=no ulcer, 1=mucosal erythema only, 2=mild mucosal edema, slight bleeding or slight erosion, 3=moderate edema, bleeding ulcers or erosions, 4=severe ulceration, erosions, edema and tissue necrosis and/or perforation. Ulcer area was determined using 3M^®^ scaled surgical transparent tape, which was fixed on a light and transparent sheet. Each cell on the tape was 1 mm^2^ in area and the number of cells was counted for measuring the ulcerated areas for each specimen. Ulcer index was measured by summing the ulcer score and the ulcer area for each colon ([@ref30][@ref31]).

For histological examination, colon tissues were individually fixed in 10% formalin, processed (dehydrated, cleared, impregnated with paraffin, blocked, sectioned in 4 μm thick slices) and stained with haematoxylin and eosin (H&E). Inflammation severity and extent as well as crypt damage were evaluated on H&E-stained and coded sections while a modification of a validated scoring system described by Cooper and coworkers([@ref32]) and Dieleman and coworkers ([@ref33]) was used. Total colitis index was measured by summing 3 subscores (inflammation severity, inflammation extent, crypt damage). Coworker pathologist unaware of treatments recorded macroscopic and histological injuries. It was implemented by using a Zeiss^®^ microscope equipped with a Sony^®^ color video camera for digital imaging.

Statistical Analysis {#sec2-9}
--------------------

Analysis of data was performed by SPSS (version 10) statistical software. Non-parametric data were analyzed by Kruskal-Wallis and Mann-Whitney U tests. Results were expressed as mean ± standard error of mean (S.E.M). Differences between groups were determined using one-way analysis of variance (ANOVA) with Scheffe as post hoc test. The minimal level of significance was identified at *P*\<0.05.

RESULTS {#sec1-3}
=======

Yield value of the extract {#sec2-10}
--------------------------

The concentrated extract yielded 14% w/w and freeze-dried CHE yielded 7%.

Analysis of the essential oil {#sec2-11}
-----------------------------

The plant fruits yielded 2.9% (v/w) of a pale-yellowish essential oil with a fresh pleasant odor. Carvone as the most important part of CEO showed hot red spot in the middle of TLC chromatogram (R~f~ = 0.5). It is a main parameter to identify and standardize caraway oil as noted in Iranian Herbal Pharmacopoeia ([@ref7]).

Macroscopic assessment {#sec2-12}
----------------------

As it is shown in [Fig. 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}, macroscopic tissue damage parameters manifested severe inflammation; hemorrhage, ulcer, and necrosis as well as thickening of colon wall in colitis control groups compared to sham groups in which no changes were observed.

![Macroscopic presentation of TNBS-induced colitis in rats. A) Sham, normal colon treated with vehicle, 2 ml/kg; B) Control colitis treated with vehicle, 2 ml/kg; C) Caraway hydroalcoholic extract treated colitis, 400 mg/kg; D) Caraway essential oil treated colitis, 400 μl/kg; E) Prednisolon treated colitis, 4 mg/kg.](JRPS-8-1-g001){#F1}

###### 

Effects of *Carum carvi* hydroalcoholic extract and essential oil on the macroscopic parameters of TNBS- induced colitis in rats.

![](JRPS-8-1-g002)

All the treatments with increasing doses of CHE and CEO were effective to reduce weight/length ratio and ulcer index (ulcer area + ulcer severity) in colon samples compared to control groups (at least *P*\<0.05) ([Table 1](#T1){ref-type="table"}). CHE and CEO also diminished ulcer features after both routes of P.O. and I.P. administration.

On the other hand, prednisolone and Asacol® significantly (*P*\<0.001) diminished macroscopic scores and weight/length ratio in colitis rats after P.O. administration. Hydrocortisone acetate had also desirable effect on macroscopic features of colitis lesions (*P*\<0.001) intraperitoneally.

Histological assessment {#sec2-13}
-----------------------

No histological damage was observed in sham groups. In control groups, microscopic assessments revealed highly severe inflammation and infiltration of white blood cells in mucus and sub-mucosal layers ([Fig. 2](#F2){ref-type="fig"}). P.O. treatment with prednisolone and Asacol® as well as parentreal hydrocortisone acetate were all effective to reduce total colitis index (inflammation severity + inflammation extent + crypt damage) in injurious colons (at least *P*\<0.05) ([Table 2](#T2){ref-type="table"}). Similar findings were obtained by increasing doses of CEO (100-400 μl/kg) and CHE (100-400 mg/kg) in comparison with control groups and there was no meaningful difference between test doses and/or plant fractions administered by different routes (*P* \> 0.05).

![microscopic presentation of TNBS-induced colitis in rats. A) Sham, normal colon treated with vehicle, 2 ml/kg; mucus layer and crypts are normal and leucocyte infiltration is absent. B) Control colitis treated with vehicle, 2 ml/kg; mucosal and submucusal inflammation as well as crypt damage and leucocyte infiltration are evident; C) Caraway hydroalcoholic extract treated colitis, 400 mg/kg; D) Caraway essential oil treated colitis, 400 μl/kg; E) Prednisolon treated colitis, 4 mg/kg. H & E staining with low power.](JRPS-8-1-g003){#F2}

###### 

Effects of *Carum carvi* hydroalcoholic extract and essential oil on the histopathologic parameters of TNBS- induced colitis in rats.
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DISCUSSION {#sec1-4}
==========

It has been described that TNBS model of experimental colitis is beneficial for the screening of drugs with anticolitic activity and has several similarities to pathological and clinical features of the human ulcerative colitis ([@ref34]).

The CHE and CEO inhibited the ulcerative lesion index both macroscopically and pathologically in accordance with the previous study reported antiulcerogenic activity for CHE in gastric ulcer ([@ref35]). Khayyal and coworkers demonstrated that different CHE produced anti-ulcerogenic effect against indomethacin-induced gastric ulcer accompanied by reduction in gastric acid output and leukotriens synthesis while mucus secretion and prostaglandin E2 release were enhanced. This was attributed to the radical scavenging, spasmolytic and immunomodultory properties of compounds found in the CHE and CEO ([@ref20]).

Our results showed that the activity of caraway test fractions was independent of the administration routes and the dose. The lower doses of CHE and CEO were efficient like the greater ones indicating high potency components within the fractions. So it seems that caraway is a valuable candidate to be considered and designed as a dosage form for marketing. Lower dose efficiency also indicates that the components are more abundant in caraway would be more responsible for these beneficial effects. For example in caraway CEO; carvone is the most dominant and important component ([@ref36]).

The results of the current study showed that administration route did not exert a significant influence on the therapeutic efficacy and activity of CHE and CEO. Two suggestions might be presented to describe this finding; Firstly, it is supposed that treatment of animals with P.O. administration of caraway fractions for a period of 5 days provided a suitable condition for systemic absorption and availability of active plant constituents as it is comparable with parenteral route. Secondly, the active constituents of CHE that has high lipid solubility similar to volatile oil constituents of CEO could be absorbed readily from GI tract and even after applying intraperitoneally are effective on colitis.

In the present study, all macroscopic and microscopic lesion parameters were improved after administration of the reference drugs. Glucocorticoids in IBD inhibit the synthesis of inflammatory cytokines (IL-1, TNF-α) and chemokines (IL-8) and decrease phospholipase A2, cyclooxygenase and NF-kappa B activity. So glucocorticoids diminish all three forms of leukoterians, prostaglandins and TNF-α as inflammatory mediators are commonly involved in IBD pathogenesis; ([@ref1][@ref4][@ref37]). Asacol® administered orally was similarly effective (compared to glucocorticoides) in TNBS-induced colitis suggesting involvement of some more molecular and/or cellular mechanisms like an important radical scavengering related mechanism, inhibition of natural killer cells (NKC), macrophages and mucosal lymphocytes ([@ref1][@ref37]). Moreover, Asacol can inhibit the cyclooxygenase and 5-lipoxygenase pathways of arachidonic acid metabolism similar to corticosteroids, in which the latter mechanism seems to be more important in IBD pathology, although the exact mechanism of Asacol® is unclear ([@ref1][@ref4]).

The terpenoid, flavonoids, fatty acids, triacylglycerols, polysaccharides, lignin and polyacetylenic compounds of caraway can reduce inflammatory cytokines and chemokines similar to glucocorticoids mechanism ([@ref38]). It seems that caraway is anticolitis with reducing the production of prostaglandin E2 and increasing the production of leucotriene B4 in human polymorphonuclear leucocytes ([@ref39]).

The most present component of *C. carvi* which is known as an anti-inflammatory agent is carvone. Carvone inhibits 5-lipoxigenase and cyclooxygenase activity so it can decrease biosynthesis of leucotriens and prostaglandins. Additionally carvone acts as a blocker of voltage dependent Ca channels resulting in probably spamolytic and anti-inflammatory effects of this active compound ([@ref7][@ref40]). The beneficial activity of *C. carvi* could also be attributed to its antioxidant properties of the caraway phenolic compounds ([@ref41]). Caraway has potent antioxidant and antibacterial activity due to their contents of carvacrol ([@ref42]). Another study showed that antioxidant activity of carvone and limonene in caraway ([@ref13]). It has emerged that the major compounds occurring in caraway are carvacrol, carvone, α-pinene, limonene, γ-terpinene, linalool, carvenone, and *p*-cymene, carveol, camphene, fenchen ([@ref43][@ref44]). Moreover Caraway fruits have immunomodulatory activity for which monoterpenes like carvone and limonene have identified ([@ref45]). It is reasonable to assume that a synergy between or within a group of compounds might be responsible for the beneficial activities of caraway for IBD therapy or prevention.

CONCLUSION {#sec1-5}
==========

In conclusion, our results suggest an advantageous therapeutic activity for CHE and CEO as an anti-inflammatory and anti-ulcerative medicinal plant for IBD conditions. This reinforces the use of this plant as an alternative remedy for IBD conditions and/or prevention of its recurrence; especially when it is effective even with low doses and in both administration routes, orally and intraperitoneally. More studies are strongly recommended to establish the mechanisms are involved and the active constituents which are really responsible for its beneficial pharmacologic actions.
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